Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

      DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

      Farhat Nasim3 Dec 2019 1:06 PM IST
      New Delhi: Communicating to all manufacturers about the Centre for Development for Advanced Computing (CDAC) guidelines for uploading various...
      Cadila Healthcare to merge with 4 subsidiaries to cut costs, overheads

      Cadila Healthcare to merge with 4 subsidiaries to cut costs, overheads

      Farhat Nasim3 Dec 2019 11:44 AM IST
      "The amalgamation is being done for consolidation of pharmaceutical business and merger simplification of corporate structure to avoid duplication of...
      Biocon, Mylan unveil biosimilar Ogivri to treat breast, gastric cancer in US

      Biocon, Mylan unveil biosimilar Ogivri to treat breast, gastric cancer in US

      Farhat Nasim3 Dec 2019 11:30 AM IST
      Ogivri is available in a 420 mg multi-dose vial and a 150 mg single-dose vial in order to provide the patients dosing and treatment flexibility,...
      Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

      Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

      Farhat Nasim3 Dec 2019 9:50 AM IST
      Siddharth Mittal takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on November 30,...
      Sanofi to sell surgical unit Seprafilm to Baxter for USD 350 million: Report

      Sanofi to sell surgical unit Seprafilm to Baxter for USD 350 million: Report

      Farhat Nasim3 Dec 2019 9:45 AM IST
      Sanofi took on Seprafilm, which is used to help manage the bleeding in abdominal and the pelvis operations, in 2011 as part of its purchase of...
      Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

      Alembic Pharma JV Aleor gets tentative USFDA nod for therapeutic equivalent of Pennsaid Topical Solution

      Farhat Nasim2 Dec 2019 3:43 PM IST
      The approved ANDA(Diclofenac Sodium Topical Solution) is therapeutically equivalent to the reference listed drug product (RLD), Pennsaid Topical...
      Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

      Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

      Farhat Nasim2 Dec 2019 11:28 AM IST
      On November 27, 2019, the US District Court (District of Massachusetts) entered a decision denying in part and granting in part Sun Pharma Ltd’s...
      SCHOTT introduces new glass tank facility at Gujarat plant

      SCHOTT introduces new glass tank facility at Gujarat plant

      Farhat Nasim1 Dec 2019 9:55 AM IST
      New Delhi: SCHOTT AG, a pharmaceutical glass manufacturer, is inaugurating its new glass tank facility in Jambusar, Gujarat following an investment of...
      Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines

      Bayer collaborates with Pharmaron to develop new molecular entities for veterinary medicines

      Farhat Nasim1 Dec 2019 9:22 AM IST
      New Delhi: Bayer and Pharmaron have entered into a global collaboration agreement to develop new molecular entities for veterinary medicines.Under the...
      Surgical Traders and Manufacturers oppose classification of popular devices as Drugs, write to Health Minister

      Surgical Traders and Manufacturers oppose classification of popular devices as Drugs, write to Health Minister

      Farhat Nasim29 Nov 2019 12:31 PM IST
      New Delhi: The recent decision of the government to classify 4 common healthcare devices namely nebulizer, blood pressure, digital thermometer,...
      UP Govt orders pull back of substandard Atorvastatin medicine from govt hospitals

      UP Govt orders pull back of substandard Atorvastatin medicine from govt hospitals

      Farhat Nasim28 Nov 2019 2:14 PM IST
      The state government, hence, issued an order on November 19 to recall the entire batch of the medicine (Atorvastatin) that was supplied to more than ...
      Centaur Pharma Ambernath facility receives EIR from USFDA

      Centaur Pharma Ambernath facility receives EIR from USFDA

      Farhat Nasim28 Nov 2019 9:30 AM IST
      Centaur Pharma has now received a formal EIR (Establishment Inspection Report) from USFDA stating the facility is CGMP compliant and the audit outcome...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok